Samotolisib
CAS: 1386874-06-1
Ref. TM-T6883
1mg | 35.00 € | ||
2mg | 52.00 € | ||
5mg | 74.00 € | ||
10mg | 113.00 € | ||
25mg | 240.00 € | ||
50mg | 421.00 € | ||
100mg | 616.00 € | ||
1ml*10 (DMSO) | 84.00 € |
Product Information
- GTPL8918, LY3023414
Samotolisib (LY3023414) is an oral ATP competitive inhibitor of the class I PI3K isoforms, DNA-PK, and mTOR. Samotolisib (LY3023414) has been used in trials studying the treatment of Neoplasm, Solid Tumor, COLON CANCER, BREAST CANCER, and Advanced Cancer, among others.
Chemical properties
Technical inquiry about: TM-T6883 Samotolisib
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.